03Recent Activity
Co-led BioOrbit's £9.8M ($13.2M) seed round with Breega for in-space pharmaceutical manufacturing.
APR 30, 2026
BioOrbit is building the platform for scalable pharmaceutical manufacturing in space, focusing on the crystallization of biologics to enable self-injectable treatments that can shift complex therapies from hospitals to home care
BioOrbit is building the platform for scalable pharmaceutical manufacturing in space, focusing on the crystallization of biologics to enable self-injectable treatments that can shift complex therapies from hospitals to home care.